-
- 抗原 See all NGDN 抗体
- NGDN (Neuroguidin, EIF4E Binding Protein (NGDN))
-
抗原表位
- AA 135-165, Middle Region
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This NGDN antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- 特异性
- This antibody recognizes human Neuroguidin.
- 纯化方法
- Purified through a Protein A column followed by peptide affinity purification
- 免疫原
- Synthetic peptide - KLH conjugated - corresponding to the central region (between 135-165aa) of human Neuroguidin
- 亚型
- Ig Fraction
- Top Product
- Discover our top product NGDN Primary Antibody
-
anti-Neuroguidin, EIF4E Binding Protein (NGDN) (AA 61-209) antibody
NGDN 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Neuroguidin, EIF4E Binding Protein (NGDN) (AA 61-209) antibodyNGDN 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 0.25 mg/mL
- 缓冲液
- PBS with 0.09 % (W/V) Sodium azide
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Avoid repeated freezing and thawing.
- 储存条件
- 4 °C/-20 °C
- 储存方法
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- 抗原
- NGDN (Neuroguidin, EIF4E Binding Protein (NGDN))
- 别名
- Neuroguidin (NGDN 产品)
- 别名
- RGD1310211 antibody, C14orf120 antibody, LCP5 antibody, NGD antibody, lpd-2 antibody, 1500001L15Rik antibody, Ngd antibody, neuroguidin antibody, ngd antibody, ngdn-B antibody, ngdn-a antibody, neuroguidin antibody, neuroguidin, EIF4E binding protein antibody, neuroguidin L homeolog antibody, Ngdn antibody, NGDN antibody, ngdn.L antibody
- 背景
- Neuroguidin is an EIF4E-binding protein that interacts with CPEB and functions as a translational regulatory protein during development of the vertebrate nervous system [Jung et al., 2006, PubMed 16705177].Synonyms: C14orf120, NGDN
- 分子量
- 35894 Da
- 基因ID
- 25983
- NCBI登录号
- NP_001036100
- 途径
- SARS-CoV-2 Protein Interactome
-
You are here:
